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Abstract
Objective: To determine the impact of Kisspeptin on male reproductive axis in a selected urban population.
Methods: The cross-sectional study was conducted at the Sindh Institute of Reproductive Medicine in collaboration
with Aga Khan University, Karachi, from July, 2017, to February, 2018, and comprised infertile males with abnormal
sperm parameters who were placed in Group A and fertile males with normal sperm parameters placed in Group B.
Serum samples were estimated for Kisspeptin, follicle stimulating hormone, luteinizing hormone, testosterone and
sex hormone-binding globulin using enzyme-linked immunosorbent assay. Data was analysed using SPSS 22.
Results: Of the 313 male subjects, 178(57%) were in Group A and 135(43%) in Group B. Median Kisspeptin levels
were higher among fertile males compared to infertile males (p<0.001). Mean follicle stimulating hormone,
luteinizing hormone and testosterone values were higher among the fertile males (p<0.001). There was significant
interaction between follicle stimulating hormone and testosterone (p<0.1).
Conclusion: Fertility in males depended on optimal secretion of Kisspeptin which exert edits effect on
hypothalamic pituitary gonadal axis to increase male reproductive hormone production.
Keywords: Kisspeptin, Infertility, Sperm parameters, Obesity. (JPMA 70: 1125; 2020)
DOI: https://doi.org/10.5455/JPMA.12861

Introduction
Infertility can be defined as the inability of a sexually
active, non-contracepting couple to achieve spontaneous
pregnancy after one year.1 It is a global problem that
entails serious sexual and social consequences that strain
the health sector and society as a whole.2 According to
Agarwal et al., male factors account for 20-70% of
infertility problems faced by the commonly quoted 15%
of couples worldwide.3 This may be due to congenital or
acquired urogenital problems, abnormalities, genetic
predisposition, immune system factor disorders of the
immune system, infections, malignancies and/or
endocrine malfunction, but 30% of the time, male
infertility presents idiopathically.4
Kisspeptin (KP) is one of the two RF-amide peptide
hormone produced from the KISS1 gene via the plasma
proteolytic cleavage of the gene product. Role of KP as a
vital activator of reproductive endocrinological activity
can be evidenced by the location of KISS1receptors in
hypothalamus, basal ganglia and periventricular area
(central nervous system [CNS]) as well as in structures like
testis, spermatozoa, ovary and endometrium. KISS1 acts
on KISS1 receptors on gonadotrophic-releasing hormone
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(GnRH) neurons and causes release, which increases the
firing rate of GnRH neurons and further
increasesLutenizing Hormone (LH) secretion by acting on
gonadotrophs.5 Studies carried out to determine the role
of KP in the regulation of the reproductive axis have
documented an increase in oocyte maturity and clinical
pregnancy rates of females after intracytoplasmic sperm
injection (ICSI), especially in cases of unexplained
infertility.6,7 Universally, researchers have mainly focussed
on females, but recent shift in healthcare dynamics have
instigated a fresh look into male infertility and the
corresponding factors that influence its extent, severity
and prevalence. Serum levels of KP have been
investigated in only limited number of studies which
don't give the insights of the causative factors of male
infertility.8,9 The current study was planned to determine
the impact of KP on male reproductive axis in a selected
urban population, and to bridge the gap by exploring the
correlative and causative links between KP and the
cascade of released hormones (Figure).

Subjects and Methods
The cross-sectional study was conducted at the Sindh
Institute of Reproductive Medicine (SIRM) in collaboration
with Aga Khan University (AKU), Karachi, from July, 2017,
to February, 2018. After approval from the AKU
ethicsreview board, the sample size was calculated to
generate a power of 80% with 5% confidence interval
(CI)10 while keeping the prevalence of male factor
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infertility at 40%.3 Based on the calculation, infertile and
fertile males aged 25-55 years regardless of their ethnic
background were enrolled for the study after getting
written informed consent from each of them. They were
classified as infertile group which comprised males with a
sperm concentration <15 × 106, decreased total sperm
motility <40% and normal morphology <4%,11 and a
fertile group which had males who had children and
sperm concentration >15 × 106, total sperm motility
>40% and normal morphology >4%.11 Male subjects with
pre-existing diabetes and hypertension, and with serious
general health status were excluded. Ten millilitreof
venous blood from ante-cubital vein was collected from
infertile males. Serum obtained by centrifugation of
blood was stored at -70°C until further analysis. Serum
follicle stimulating hormone (FSH) was determined by
using commercially available kit for Human FSH Enzyme
Immunoassay (Kit Cat. No KAPD1288 by DIA source
Immuno Assays S.A. Belgium). Serum LH estimation was
made using commercially available kit for Human LH
Enzyme Immunoassay (Kit Cat. No KAPD1289 by DIA
source Immuno Assays S.A. Belgium). For Elecsys FSH
immunoassay, the inter-assay coefficient of variation (CV)
<6% and intra-assay CV<3% were used. For Elecsys LH
immunoassay the inter-assay
CV was <6%, and intra-assay
CV was <5%. Serum sex
hormone-binding globulin
(SHBG) estimation was done
using commercially available
kit for SHBG Enzyme
Immunoassay (Kit Cat. No
10222 by Glory Science Co,
Ltd USA) following the
manufacturer's
protocol.
Serum KP was measured
using KISS1 enzyme-linked
immunosorbent assay (ELISA)
Kit (Cat.No: YHB1811Hu,
Glory BioScience, USA)
following the manufacturer's
protocol. The analytical
sensitivity was 10.16 ng/L and
intra- and inter-assay CVs was
less than 10% and 12%,
respectively.
Data was analysed using SPSS
22. Descriptive statistics were
computed for categorical
variables by computing their
frequencies and percentages,
assessed by chi-square where

expected frequency in each cell was >5 and Fisher's exact
test where any one cell had frequency <5. The distribution
of quantitative variables was computed by their means
and standard deviations/ median and interquartile range
(IQR) depending onthe normality of the data, and
assessed by independent t test / Mann Whitney test.
Correlation was assessed between quantitative variables
by Pearson correlation for normally distributed data, and
spearman correlation for non-normally distributed data.
Unadjusted and adjusted prevalence ratio (PRs) with their
95% CIs were reported using simple and multiple Cox
regression. All plausible interactions and confounding
factors were assessed.

Results
Of the 313 male subjects, 178(57%) were infertile and
135(43%) were fertile. Median KP levels were higher
among fertile males compared to infertile males (p
<0.001). The mean age of the fertile participants was
higher, but infertile males had a higher BMI and Body fat
percentage (BF%) value compared to the fertile group
(p<0.001). Mean FSH, LH and testosterone values were
higher among fertile males (p<0.001). Median SHBG was
higher among fertile males (p<0.001). A strong positive

Increased adiposity plays a pivotal role in disturbing the hypothalamic-pituitary-gonadal axis leading to decreased testosterone
ultimately causing male infertility.
GnRH: Gonadotropin releasing hormone; KP: Kisspeptin; LR: Leptin receptor;
LH: Leutinizing hormone; FSH: Follicular stimulating hormone.

Figure: Possible pathophysiology involved in causing male infertility.
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Table-1: Clinical and biochemical characteristic of fertile and infertile males.
Factors

Infertile (n=178)
Mean ± SD

Age (in years)
BMI (in kg/m2)
Body Fat (%)
FSH (in mIU/ml)
LH (in mIU/ml)
Testosterone (in ng/ml)

SHBG (nmol/L)
Kisspeptin (ng/ml)

33.74 ± 5.67
26.67 ± 3.59
34.37±4.66
3.41 ± 1.97
5.45 ± 2.90
3.35 ± 1.92

Infertile (n=135) P value
Mean ± SD
37.65 ± 6.12
24.76 ± 3.08
32.97±4.06
6.31 ± 2.50
9.96 ± 2.58
8.16 ± 1.38

<0.001
<0.001
0.006
<0.001
<0.001
<0.001

Median (IQR)
Median (IQR)
15.44 (12.06-18.95) 32.06 (25.98-30.71) <0.001
6.25 (5.65-6.95)
16.25(15.6-43.75) <0.001

BMI, the prevalence of being infertile increased by 6.9%.
Likewise, the males who were obese (> 25kg/m2) were
1.604 times more likely to be infertile compared to those
who were of normal weight (CI:1.065-2.417).
In the final Cox regression model which included KP, FSH
and testosterone, it was observed that after adjusting for
FSH and testosterone, with every one unit increase in KP,
the prevalence of being infertile decreased by 2.7%. There
was significant interaction between FSH and testosterone
(p<0.1). Hence, with every 1 unit rise in serum
testosterone level, the FSH led to 4.6% decrease in
infertility (Table-2).

Discussion
Normal weight (18 - 22.9 kg/m2)
Overweight (23 - 24.9 kg/m2)
Obese (> 25 kg/m2)

Absolute
count (%)
28 (15.7%)
25 (14.0%)
125(70.2%)

Absolute
count (%)
41 (30.4%)
27 (20.0%)
67 (49.6%)

<0.001

*Significant at p value <0.05
SD: Standard deviation; BMI: Body mass index; FSH: Follicle stimulating hormone;LH: Luteinizing
hormone; SHBG: Sex hormone-binding globulin.

correlation was observed between LH and testosterone
(r=0.954; p=0.002) and between SHBG and LH (rho=0.933;
p<0.001) (Table-1).
Univariate analysis showed that with every one unit
increase in KP, the prevalence of being infertile was
decreased by 6.6%. Similarly, with every 1 unit increase in
age (year), FSH (mIU/ml), LH (mIU/ml), testosterone
(ng/ml) and SHBG, the prevalence of being infertile was
decreased by 4.7%, 20%, 15.7%, 22.4% and 6.9%
respectively. Moreover, with every 1 kg/m2 increase in

The study observed low serum KP levels with reduced LH,
FSH, testosterone, SHBG levels in male infertile subjects.
The findings are similar to an earlier study.12 Further
analysis showed that higher serum KP levels were
associated with a significant increase in reproductive
hormones, which suggested its crucial role in the central
regulation of male reproductive axis and fertility. KP also
exerts peripheral effects alongwith its central regulation
resulting from its steroid-independent role in
intermediating
stress-induced
suppression
of
reproductive functions.13
The impact of KP on hypothalamo-pituitary gonadal
(HPG) axis can further be complemented by the incidence
of hypogonadotropic hypogonadism presenting with
absent or delayed reproductive function and pubertal
maturation, caused by mutations in the gene encoding
for a G protein-coupled receptor (GPR54)of KISS1R. This
key was further substantiated by a demonstration in
which mice lacking functional GPR54 or KISS1 genes were

Table-2: Interface of Kisspeptin (KP), clinical and hormonal profile and the risk of infertility by univariate and multivariate analysis.
Factors
Age (year)
Normal weight
Overweight
Obese
Body Fat (%)
LH (in mIU/ml)
0.843(0.805-0.882)
SHBG nmol/L
Kisspeptin(ng/ml)
FSH (mIU/ml)
Testosterone (ng/ml)
FSH* Testosterone

Unadjusted Prevalence Ratio (95% CI)

P value

Adjusted Prevalence Ratio (95% CI)

P value

0.953(0.929-0.978)
Reference
1.185(0.691-2.032)
1.604(1.065-2.417)
1.031(0.998-1.066)

<0.001*
-0.047
0.002
0.07

------

--

<0.001
0.931(0.912-0.950)
0.934 (0.912-0.957)
0.796(0.740-0.855)
0.776(0.735-0. 820)
--

-<0.001
<0.001
<0.001
<0.001
--

--0.973 (0.954-0.993)
1.091(0.957-1.243)
1.011(0.886-1.153)
0.954(0.927-0.983)

*Significant at p value < 0.05
# Significant at p value < 0.1
FSH: Follicle stimulating hormone;LH: Luteinizing hormone; SHBG: Sex hormone-binding globulin.
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----

-0.008*
0.193
0.873
0.002
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phenocopies of the humans affected.14 Jayasena et al.
reported that exogenously-administered Kisspeptin-10
bolus even at low doses stimulated gonadotropin
release15 in males primarily but also in women during the
pre-ovulatory phase of the menstrual cycle.
The observation by the current study of increase in FSH
and LH secretion is supported by studies that
documented KP as a powerful stimulator of LH and FSH
release, both after intra-cerebral and systemic
administration of the peptide.16 The increased LH
secretion in fertile males with increased KP is supported
by Pinilla et al. who reported that KP plays a crucial role in
increased LH secretion, and to lesser extent FSH secretion
as well.5 George et al. further complemented this report
by discovering that exogenous KP-10 administration
resulted in an increase in LH pulse frequency and
secretion, with increased testosterone levels in the
hypogonadal men suffering from type 2 diabetes.17 We
observed increased concentration of both LH and FSH
which is contrary to a study which documented greater
sensitivity of LH release to the stimulatory effect of KP in
comparison to FSH.16
Down-streaming the HPG axis, KP potentially increased
the serum testosterone levels in normal males which is
comparable to Dhillo et al.18 In addition, it has also been
demonstrated that systemic KP administration in males
who are infertile and/or have azoospermia can cause
increased testosterone secretion in addition to LH and
FSH. However, chronic increase may lead to testicular
atrophy, causing a drop in testosterone levels and an
increase, decrease or no change in LH and FSH levels.18
We also observed a strong positive correlation between
LH and testosterone. This causal relationship and the
reversibility of the levels has been authenticated with a
decrease in weight loss.19
Obesity alters fertility both centrally and peripherally. The
anticipated patho-physiological mechanisms thus explain
the multi-factorial relationships involved. Apart from
influencing the HPG axis and the aromatisation, truncal
obesity also causes hypoxaemia during sleep apnoea,
which might disrupt the morning testosterone
secretion.20 Additionally, there is loss of sperm
deoxyribonucleic acid (DNA) integrity caused by the
activation of seminal macrophage due to enhanced redox
activity in obese men.21 Nevertheless the psychological
influence can also lead to erectile dysfunctions.22
Literature insinuates links between degree of obesity and
male fertility by affecting the total testosterone,oestrogen
and reduced Sertoli cell functions.23 This might be on
account of increased white adipose tissue present in
obese males. White adipocytes are accountable for the
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aromatase activity within the adipocytes that converts
available testosterone to estradiol, resulting in decreased
testosterone level in such individuals. Simultaneously,
oestrogens stored in the fat tissues act as a suppressor on
the HPG axis. Decreasing the GnRH release ultimately
lowers the secretion of LH and FSH, leading to diminished
gonadal testosterone release Therefore, it is possible that
the high BF% in our subjects could have an indirect effect
on testosterone levels modulating the HPG axis. Leptin is
an adipokine that regulates body composition and satiety
(Figure). In addition, it also stimulates GnRH neurons in
the hypothalamus to induce LH release and subsequent
testicular stimulation of testosterone release under
normal conditions.24 A previous study showed a relation
of Leptin-KP axis in female infertility; expressed by
maximum number of clinical pregnancies in the group
that showed strongest relationship between serum
Leptin and KP levels.25 GnRH neurons have little or no
leptin receptor expression but possess the KP receptor
and KP neurons that express the leptin receptor, thus
modulating the GnRH secretion. However, hypothalamic
leptin resistance is common in obesity, leading to a loss of
feedback stimulation of testosterone production.25
After adjusting for covariates FSH and testosterone,
chances of becoming infertile increased with every one
unit increase in KP. The causative effect between KP levels
and the changes in the reproductive status, however,
needs to be explored further.The current study is
complimentary in nature because majority of studies
have focussed on the hypothalamic and pituitary impact
of KP administration as opposed to serum hormonal and
protein biomarker levels.

Conclusion
KP plays an important role in male fertility by increasing
the production of hormones of the male reproductive
axis; namely FSH, LH and testosterone. Absence of
negative feedback inhibition of KP by increased
testosterone supports its production from peripheral
reproductive organs besides central nervous system.
Disclaimer: None.
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